GL · Globe Life Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.56B | - | $1.51B | $1.48B | $1.48B | - | $1.46B | $1.44B | $1.42B | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | $379.15M | $334.91M | $326.72M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | $89.19M | $83.11M | $80.41M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | $334.13M | - | $477.10M | $313.30M | $316.08M | - | $383.12M | $338.60M | $327.43M | - |
| Interest Expense | $34.00M | - | $36.13M | $34.88M | $34.99M | - | $31.39M | $31.40M | $28.62M | - |
| Income Tax | $63.61M | - | $89.26M | $60.55M | $61.52M | - | $73.96M | $63.97M | $60.71M | - |
| Net Income | $270.53M | - | $387.84M | $252.75M | $254.56M | - | $302.99M | $258.36M | $254.22M | - |
| EPS - Basic | $3.45 | - | $4.81 | $3.09 | $3.05 | - | $3.45 | $2.83 | $2.71 | - |
| EPS - Diluted | $3.39 | - | $4.73 | $3.05 | $3.01 | - | $3.44 | $2.83 | $2.67 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $255.21M | $144.70M | $302.72M | $239.12M | $232.27M | $165.32M | $134.55M | $87.91M | $83.55M | $103.16M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $30.97B | $30.81B | $30.53B | $29.81B | $29.71B | $29.08B | $29.56B | $28.30B | $28.57B | $28.05B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $2.32B | $2.32B | $2.32B | $2.33B | $2.32B | $2.32B | $2.32B | $1.63B | $1.63B | $1.63B |
| Total Liabilities | $24.88B | $24.84B | $24.84B | $24.39B | $24.28B | $23.77B | $24.92B | $23.07B | $23.53B | $23.56B |
| Stockholders' Equity | $6.08B | $5.97B | $5.69B | $5.42B | $5.43B | $5.31B | $4.64B | $5.23B | $5.04B | $4.49B |
| Retained Earnings | $8.79B | $8.55B | $8.81B | $8.45B | $8.22B | $8.00B | $8.23B | $7.94B | $7.71B | $7.48B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $420.94M | - | - | - | $431.89M | - | - | - | $350.81M | - |
| Investing Cash Flow | ($281.26M) | - | - | - | ($239.95M) | - | - | - | ($731.94M) | - |
| Financing Cash Flow | ($29.63M) | - | - | - | ($124.46M) | - | - | - | $356.96M | - |
| CapEx | $24.91M | - | - | - | $11.75M | - | - | - | $9.11M | - |
| Free Cash Flow | $396.03M | - | - | - | $420.14M | - | - | - | $341.70M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | 26.1% | 23.3% | 23.1% | - |
| Operating margin | 21.4% | - | 31.5% | 21.2% | 21.4% | - | 26.3% | 23.5% | 23.1% | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | 17.3% | - | 25.6% | 17.1% | 17.2% | - | 20.8% | 17.9% | 18.0% | - |
| Free cash flow margin | 25.4% | - | - | - | 28.4% | - | - | - | 24.1% | - |
| FCF / Net income | 1.46 | - | - | - | 1.65 | - | - | - | 1.34 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | 6.1% | 5.8% | 5.7% | - |
| Effective tax rate | 19.0% | - | 18.7% | 19.3% | 19.5% | - | 19.6% | 19.8% | 19.3% | - |
| Return on assets | 0.9% | - | 1.3% | 0.8% | 0.9% | - | 1.0% | 0.9% | 0.9% | - |
| Return on equity | 4.4% | - | 6.8% | 4.7% | 4.7% | - | 6.5% | 4.9% | 5.0% | - |
| Return on invested capital | 3.2% | - | 4.8% | 3.3% | 3.3% | - | 4.4% | 4.0% | 4.0% | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 0.38 | 0.39 | 0.41 | 0.43 | 0.43 | 0.44 | 0.50 | 0.31 | 0.32 | 0.36 |
| Debt / Assets | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.06 | 0.06 | 0.06 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 9.8x | - | 13.2x | 9.0x | 9.0x | - | 12.2x | 10.8x | 11.4x | - |
| Equity multiplier | 5.09 | 5.16 | 5.37 | 5.50 | 5.48 | 5.48 | 6.37 | 5.41 | 5.67 | 6.25 |
| Liabilities / Assets | 0.80 | 0.81 | 0.81 | 0.82 | 0.82 | 0.82 | 0.84 | 0.82 | 0.82 | 0.84 |
| Efficiency | ||||||||||
| Asset turnover | 0.05 | - | 0.05 | 0.05 | 0.05 | - | 0.05 | 0.05 | 0.05 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 41.1x | - | 30.2x | 40.8x | 43.8x | - | 30.8x | 29.1x | 43.6x | - |
| P / B | 1.8x | - | 2.1x | 1.9x | 2.1x | - | 2.0x | 1.4x | 2.2x | - |
| P / S | 7.1x | - | 7.8x | 6.9x | 7.5x | - | 6.4x | 5.2x | 7.8x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 5.3% | - | 4.0% | 2.8% | 4.5% | - | 5.2% | 8.6% | 7.2% | - |
| Revenue CAGR (3y) | 5.7% | - | 5.4% | 4.6% | 4.2% | - | 4.4% | 4.3% | 3.8% | - |
| Revenue CAGR (5y) | 4.3% | - | 4.8% | 4.6% | 5.5% | - | 5.0% | 5.0% | 4.8% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | 18.1% | 7.9% | 7.1% | - |
| Operating income growth (YoY) | 5.7% | - | 24.5% | -7.5% | -3.5% | - | 18.9% | 9.1% | 7.3% | - |
| Net income growth (YoY) | 6.3% | - | 28.0% | -2.2% | 0.1% | - | 17.9% | 20.0% | 13.7% | - |
| EPS growth (YoY) | 12.6% | - | 37.5% | 7.8% | 12.7% | - | 28.4% | 26.3% | 17.1% | - |
| EPS CAGR (3y) | 14.1% | - | 35.5% | 19.4% | 22.4% | - | 23.2% | 13.8% | 16.2% | - |
| EPS CAGR (5y) | 14.8% | - | 21.9% | 13.5% | 14.6% | - | 13.6% | 11.1% | 10.1% | - |
| FCF growth (YoY) | -5.7% | - | - | - | 23.0% | - | - | - | -27.2% | - |
| FCF CAGR (5y) | 2.1% | - | - | - | 4.7% | - | - | - | -3.9% | - |
| Book value growth (YoY) | 12.1% | 12.6% | 22.6% | 3.7% | 7.7% | 18.2% | 0.3% | 31.3% | 439.8% | -8.4% |
Peer comparison
Same SIC group: Life Insurance
Comparing GLOBE LIFE INC. against the 5 most active filers in the same SIC group.
Dividends
$1.14/share trailing 12 months · +15.2% YoY
| Ex-date | Per share |
|---|---|
| Apr 2, 2026 | $0.3300 |
| Jan 5, 2026 | $0.2700 |
| Oct 3, 2025 | $0.2700 |
| Jul 3, 2025 | $0.2700 |
| Apr 3, 2025 | $0.2700 |
| Jan 6, 2025 | $0.2400 |
| Oct 4, 2024 | $0.2400 |
| Jul 5, 2024 | $0.2400 |
| Apr 4, 2024 | $0.2400 |
| Jan 4, 2024 | $0.2250 |
| Oct 5, 2023 | $0.2250 |
| Jul 3, 2023 | $0.2250 |
| Mar 31, 2023 | $0.2250 |
| Jan 5, 2023 | $0.2080 |
| Oct 6, 2022 | $0.2080 |
| Jul 1, 2022 | $0.2080 |
| Apr 1, 2022 | $0.2080 |
| Jan 6, 2022 | $0.1980 |
| Oct 1, 2021 | $0.1980 |
| Jul 1, 2021 | $0.1980 |
| Apr 1, 2021 | $0.1980 |
| Jan 7, 2021 | $0.1880 |
| Oct 2, 2020 | $0.1880 |
| Jul 2, 2020 | $0.1880 |